Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775748 · ClinicalTrials.gov registry record · NA
Effect of Concord Grape Juice on Endothelial Function
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT01775748 is a NA study that has completed, run by Boston University. The registered enrollment target is 77 participants.
The verdict
NCT01775748, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The study will compare Concord grape juice to a beverage that contains no grape flavonoids, but has a similar appearance and taste (placebo juice). A total of 60 overweight and obese participants over age 50 will be enrolled. Each participant will drink each beverage for 4 weeks with a 2-week rest period between two beverage consumption periods. The order of beverages (grape juice first or placebo juice first) will be randomized. The investigators will use ultrasound to measure brachial artery flow-mediated dilation, a measure of endothelial vasodilator function. The investigators will also collect blood samples to further assess the cardiovascular effects of grape juice. The aim of the study is to determine whether Concord grape juice improves endothelial function in patients at risk who do not have cardiovascular disease and may provide information that would guide dietary recommendations. The results may also be used by the sponsor to substantiate claims and labeling of their product.
Interventions
- OTHER Active Concord Grape Juice 12 oz per day
- OTHER Placebo Grape Juice 12 oz per day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2014-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775748
The ClinicalTrials.gov registry entry for NCT01775748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Concord Grape Juice 12 oz per day is the first listed.
NCT01775748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01775748 about?
NCT01775748 is a clinical study titled "Effect of Concord Grape Juice on Endothelial Function". The study will compare Concord grape juice to a beverage that contains no grape flavonoids, but has a similar appearance and taste (placebo juice). A total of 60 overweight and obese participants over age 50 will be enrolled. Each participant will drink each beverage for 4 weeks with a 2-week rest p...
What is the current status of trial NCT01775748?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2013-01-01. Estimated completion is 2014-03-19.
What interventions are being tested in trial NCT01775748?
The interventions under investigation include: Active Concord Grape Juice 12 oz per day (OTHER), Placebo Grape Juice 12 oz per day (OTHER).
Who is sponsoring clinical trial NCT01775748?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.